My Top Pharma Stock to Buy in the Next Market Crash

Despite high unemployment and a fraught economic climate, the stock market has fully recovered since bottoming out earlier this year. All three major U.S. market indexes, the S&P 500, Nasdaq Composite, and Dow Jones Industrial Average, are up by more than 50%. But as history tells us, it's only a matter of time before we face another crash. Unexpected market corrections are regular events marked by at least a 10% decline in stock prices. But when they inevitably happen, dedicated long-term investors shouldn't jump to escape the market.

Watching your portfolio plunge will test your resolve. But it's essential for investors to remember that the market will recover after the next downturn. The market has recovered from every single downturn in its history. That's a resounding 38 market correction recoveries since 1950. Instead of panic-selling when stocks plunge, a dip can serve investors who know how to look for great investment opportunities at a discount. In that spirit, Bristol Myers Squibb (NYSE: BMY) is one pharma stock I believe will be a great pick when the market crashes again.